<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Approximately 20 % of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> have synchronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> at the time of diagnosis </plain></SENT>
<SENT sid="1" pm="."><plain>In some instances it is difficult to determine the best treatment strategy in these patients </plain></SENT>
<SENT sid="2" pm="?"><plain>For example, should the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> be removed in those patients with unresectable <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> and who do not have any symptoms of the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> </plain></SENT>
<SENT sid="3" pm="?"><plain>Or which operation should be performed first in patients with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> and synchronous resectable <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Unfortunately, there are no clear answers to these questions from prospective randomized trials </plain></SENT>
<SENT sid="5" pm="."><plain>In the present article retrospective studies are analyzed in order to define the best possible treatment strategy for patients with synchronous colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
</text></document>